2014
DOI: 10.1371/journal.pone.0106472
|View full text |Cite
|
Sign up to set email alerts
|

A Comparative Analysis of Constitutive Promoters Located in Adeno-Associated Viral Vectors

Abstract: The properties of constitutive promoters within adeno-associated viral (AAV) vectors have not yet been fully characterized. In this study, AAV vectors, in which enhanced GFP expression was directed by one of the six constitutive promoters (human β-actin, human elongation factor-1α, chicken β-actin combined with cytomegalovirus early enhancer, cytomegalovirus (CMV), simian virus 40, and herpes simplex virus thymidine kinase), were constructed and introduced into the HCT116, DLD-1, HT-1080, and MCF-10A cell line… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
21
1

Year Published

2015
2015
2022
2022

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 37 publications
(25 citation statements)
references
References 61 publications
1
21
1
Order By: Relevance
“…The EF‐1α promoters have primarily been studied for transgene expression in gene therapy vectors, showing stable expression in proliferating cultures compared to CMV promoters . In CHO cells, Spencer et al introduced single‐copy GFP transgenes driven by minimal CMV and EF‐1α promoters and found that EF‐1α clones were less stable than the CMV clones.…”
Section: Discussionmentioning
confidence: 99%
“…The EF‐1α promoters have primarily been studied for transgene expression in gene therapy vectors, showing stable expression in proliferating cultures compared to CMV promoters . In CHO cells, Spencer et al introduced single‐copy GFP transgenes driven by minimal CMV and EF‐1α promoters and found that EF‐1α clones were less stable than the CMV clones.…”
Section: Discussionmentioning
confidence: 99%
“…AAV-based gene targeting assays (an assay based on the Hyg R –5′ EGFP reporter system as well as assays targeting PIGA exon 6 and PIGA intron 5, respectively) were performed as previously described with some modifications ( 10 , 11 , 38 ). For all AAV-based gene targeting assays, AAV particles (serotype 2) were produced by co-transfection of HEK293T cells with AAV-based targeting plasmids along with the plasmids pAAV-RC and pHelper included in the AAV Helper-Free System (Agilent Technologies).…”
Section: Methodsmentioning
confidence: 99%
“…This unique property permits gene editing, and effi cient gene targeting by AAV vectors has been achieved in human ES cells and iPS cells [ 34 -36 ]. Damdindorj et al [ 37 ] reported that when used in an AAV vector, the CMV promoter provided stable and robust gene expression in cancer cell lines; however, this promoter does not seem to be preferable for noncancerous cell lines and for the purpose of AAV-based gene targeting. Further studies are needed to identify the most suitable constitutive promoter for the application of AAV vectors to precise genetic manipulation of iPS cells, which could have great scientifi c and therapeutic potential.…”
Section: Aav Vectorsmentioning
confidence: 99%